HomeCompareAIKI vs VICI

AIKI vs VICI: Dividend Comparison 2026

AIKI yields 56.18% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $449.5K in total portfolio value· pulled ahead in Year 10
10 years
AIKI
AIKI
● Live price
56.18%
Share price
$3.56
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$539.3K
Annual income
$119,796.88
Full AIKI calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — AIKI vs VICI

📍 VICI pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAIKIVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AIKI + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AIKI pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AIKI
Annual income on $10K today (after 15% tax)
$4,775.28/yr
After 10yr DRIP, annual income (after tax)
$101,827.35/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, VICI beats the other by $427,944.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AIKI + VICI for your $10,000?

AIKI: 50%VICI: 50%
100% VICI50/50100% AIKI
Portfolio after 10yr
$764.0K
Annual income
$371,529.10/yr
Blended yield
48.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

AIKI
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.9
Piotroski
6/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AIKI buys
0
VICI buys
0
No recent congressional trades found for AIKI or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAIKIVICI
Forward yield56.18%6.57%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$539.3K$988.8K
Annual income after 10y$119,796.88$623,261.32
Total dividends collected$441.4K$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: AIKI vs VICI ($10,000, DRIP)

YearAIKI PortfolioAIKI Income/yrVICI PortfolioVICI Income/yrGap
1$16,318$5,617.98$11,368$948.43+$5.0KAIKI
2$26,028$8,567.67$13,339$1,493.16+$12.7KAIKI
3$40,622$12,771.79$16,326$2,426.21+$24.3KAIKI
4$62,094$18,628.85$21,123$4,112.15+$41.0KAIKI
5$93,054$26,613.05$29,379$7,368.23+$63.7KAIKI
6$136,840$37,273.01$44,804$14,191.64+$92.0KAIKI
7$197,645$51,226.14$76,658$29,972.12+$121.0KAIKI
8$280,629$69,148.09$150,894$71,015.81+$129.7KAIKI
9$392,030$91,757.54$350,814$193,582.47+$41.2KAIKI
10← crossover$539,269$119,796.88$988,809$623,261.32$449.5KVICI

AIKI vs VICI: Complete Analysis 2026

AIKIStock

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

Full AIKI Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this AIKI vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AIKI vs SCHDAIKI vs JEPIAIKI vs OAIKI vs KOAIKI vs MAINAIKI vs NNNAIKI vs EPRTAIKI vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.